Pauwels P J, Palmier C, Briley M
Laboratory of Cellular Neurobiology, Centre de Recherche Pierre Fabre, Castres, France.
Biochem Pharmacol. 1993 Aug 3;46(3):535-8. doi: 10.1016/0006-2952(93)90531-z.
Radioligand binding measurements were performed in membranes of sheep caudate nucleus using [3H]5-hydroxytryptamine (5-HT). [3H]5-HT labeled a population of high affinity binding sites with a Kd of 1.9 +/- 0.1 nM and a Bmax of 19.8 +/- 2.2 fmol/mg tissue. Combined 5-HTID/E binding sites were the predominant 5-HT1 subtype, accounting for 78% of the total population of 5-HT1 binding sites. 5-Carboxamidotryptamine (5-CT) and sumatriptan yielded inhibition curves which best fitted a two-site model with high affinity values of 0.8 and 10.1 nM, and 1000 and 206 nM for their low affinity components. The proportion of the high affinity 5-CT and sumatriptan binding sites was 79 and 72%. The binding affinity profile of 5-HT1D binding sites [5-CT > 5-HT > d-LSD > 5-MeOT > sumatriptan > RU 24,969 > metergoline > tryptamine = rauwolscine = methylsergide > yohimbine = methiothepin > TFMPP = 8-OH-DPAT > 2-methyl-5-HT > mCPP = quipazine = CP 93,129 > ketanserin > (-)-propranolol = haloperidol = ipsapirone] compares well to that reported for 5-HT1D receptor sites in human caudate and cortex (correlation coefficient: 0.99 and 0.98). The present results indicate that sheep caudate nucleus is a valid tissue for studying interaction of compounds with 5-HT1D binding sites in the relative absence of 5-HT1E binding sites.
使用[3H]5-羟色胺(5-HT)对绵羊尾状核膜进行放射性配体结合测定。[3H]5-HT标记了一群高亲和力结合位点,其解离常数(Kd)为1.9±0.1 nM,最大结合容量(Bmax)为19.8±2.2 fmol/mg组织。5-HT1D/E结合位点合并后是主要的5-HT1亚型,占5-HT1结合位点总数的78%。5-羧酰胺色胺(5-CT)和舒马曲坦产生的抑制曲线最符合双位点模型,其高亲和力值分别为0.8和10.1 nM,低亲和力成分的值分别为1000和206 nM。高亲和力的5-CT和舒马曲坦结合位点的比例分别为79%和72%。5-HT1D结合位点的结合亲和力谱[5-CT>5-HT>d-LSD>5-甲氧基色胺>舒马曲坦>RU 24,969>美替拉酮>色胺=萝芙辛=甲基麦角新碱>育亨宾=甲硫哒嗪>TFMPP = 8-羟基二丙胺基四氢吡啶>2-甲基-5-HT>mCPP = 喹哌嗪 = CP 93,129>酮色林>(-)-普萘洛尔 = 氟哌啶醇 = 伊沙匹隆]与人类尾状核和皮质中报道的5-HT1D受体位点的亲和力谱比较良好(相关系数分别为0.99和0.98)。目前的结果表明,在相对缺乏5-HT1E结合位点的情况下,绵羊尾状核是研究化合物与5-HT1D结合位点相互作用的有效组织。